Who Supplies Heparin to India from JAPAN

To import finished pharmaceutical formulations containing Heparin (HS Code 30049099) into India, the following regulatory steps are mandatory:

1. 1Import License: Obtain an Importer Exporter Code (IEC) from the Directorate General of Foreign Trade (DGFT).
2. 2CDSCO Registration: Secure registration from the Central Drugs Standard Control Organisation (CDSCO) for the specific formulation.
3. 3Form CT-20/40/41: Depending on the product, submit the appropriate form to CDSCO.
4. 4DCGI Approval: Ensure approval from the Drugs Controller General of India (DCGI) for the product.
5. 5No Objection Certificate (NOC): If required, obtain an NOC from the Ministry of Health and Family Welfare.

The registration process typically spans 6-12 months, contingent on the product's complexity and completeness of documentation.

Imported Heparin formulations must undergo stringent quality control measures:

1. 1CDSCO-Approved Laboratory Testing: Conduct tests in laboratories recognized by CDSCO to verify compliance with Indian standards.
2. 2Batch-Wise Requirements: Each batch must be accompanied by a Certificate of Analysis (CoA) detailing test results.
3. 3Stability Data: Provide stability data adhering to International Council for Harmonisation (ICH) guidelines, specifically for Zone IV conditions.
4. 4Indian Pharmacopoeia Standards: Ensure formulations meet the standards set forth in the Indian Pharmacopoeia.
5. 5Port Inspection: Customs drug inspectors perform inspections at entry points to verify compliance with regulatory standards.

These measures are enforced to guarantee the safety and efficacy of imported pharmaceutical products.

Between 2024 and 2026, India has implemented several policy updates affecting pharmaceutical imports:

1. 1CDSCO Regulatory Updates: Enhanced scrutiny and documentation requirements for imported pharmaceutical products.
2. 2PLI Scheme Impact: The Production Linked Incentive (PLI) scheme has incentivized domestic manufacturing, potentially reducing reliance on imports.
3. 3Bilateral Agreements with Japan: Strengthened trade relations have facilitated smoother import processes for Japanese pharmaceutical products.

These developments aim to bolster domestic production while ensuring the availability of essential imported medicines.

India imports finished Heparin formulations to meet specific therapeutic needs not fully addressed by domestic production:

1. 1Patented Formulations: Certain innovative Heparin formulations are protected by patents, necessitating imports.
2. 2Specific Dosage Forms: Unique dosage forms required for particular patient demographics are often sourced internationally.
3. 3Domestic Capacity vs. Import Dependency: While India has a robust pharmaceutical industry, some specialized Heparin formulations are not manufactured domestically, leading to import dependency.
4. 4Market Size: The Indian Heparin market is substantial, with imports playing a crucial role in meeting the country's therapeutic demands.

These factors underscore the importance of imports in fulfilling India's Heparin requirements.

The import duty structure for Heparin formulations under HS Code 30049099 is as follows:

1. 1Basic Customs Duty (BCD): 10%
2. 2Education Cess: 2%
3. 3Secondary Higher Education Cess: 1%
4. 4Countervailing Duty (CVD): 6%
5. 5Integrated Goods and Services Tax (IGST): 12%

The total landed duty amounts to approximately 17.10%, calculated as follows:

• Total Duty: BCD + Education Cess + Secondary Higher Education Cess + CVD = 10% + 2% + 1% + 6% = 19%
• Abatement: 35%
• Effective Duty: 19% - (19% * 35%) = 17.10%

This structure is standard for pharmaceutical imports under this HS code.

India sources Heparin formulations from Japan due to several competitive advantages:

1. 1Patents and Specialized Dosage Forms: Japan offers patented Heparin formulations and specialized dosage forms not available domestically.
2. 2Quality Assurance: Japanese manufacturers are renowned for high-quality standards and adherence to international regulations.
3. 3Regulatory Compliance: Japan's pharmaceutical products meet stringent international standards, facilitating smoother import processes.

While other countries like China, Germany, and the US also supply Heparin formulations, Japan's unique offerings and quality standards make it a preferred source for certain products.